Evidence map›Paper›PMID 40291576›Full record

ArticleWorld journal of clinical cases2025

Concurrent occurrence of adenocarcinoma and urothelial carcinoma of the prostate: Coexistence mechanisms from multiple perspectives.

Xu-Chang Liu, Yu-Xiang Liu, Chun Liu

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of clinical cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xu-Chang LiuThe No. 1 Clinical Medical School, Shanxi Medical University, Taiyuan 030001, Shanxi Province, China.
Yu-Xiang LiuDepartment of Nephrology, Shanxi Provincial People's Hospital, Taiyuan 030012, Shanxi Province, China.
Chun LiuThe No. 1 Clinical Medical School, Shanxi Medical University, Taiyuan 030001, Shanxi Province, China. sxtyliuchun@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article discusses the coexistence of prostate adenocarcinoma and prostate urothelial carcinoma. Combining existing literature and research results, the potential mechanisms of the co-occurrence of these two cancers are explored, including the role of androgen receptor, gene mutations, and their complex interactions in cell signaling pathways,

Indexed as

Coexistence mechanismProstate adenocarcinomaProstate urothelial carcinomaTransformation mechanismTumor

Identifiers

PMID40291576
PMCPMC11718564

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.